Healthcare -
Biotechnology - NASDAQ - US
$ 7.28
-4.98 %
$ 8.18 M
Market Cap
-0.22
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
HCW Biologics Inc.
| Net Income | -30 M |
| Depreciation & Amortization | 1.18 M |
| Capital Expenditures | -262 K |
| Stock-Based Compensation | 1.01 M |
| Change in Working Capital | 13.6 M |
| Others | 775 K |
| Free Cash Flow | -14.5 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (30.0) | (25.0) | (14.9) | (12.9) | (5.8) | (7.3) |
| Depreciation & Amortization | 1.2 | 1.1 | 0.7 | 0.5 | 0.6 | 0.4 |
| Deferred Income Tax | 0 | 0 | 0 | (0.5) | (4.3) | 79 K |
| Stock Based Compensation | 1.0 | 1.0 | 1.1 | 0.4 | 21.9 K | 1.76 K |
| Other Operating Activities | 418 | 5.0 | 0.2 | 28.3 K | 4.3 | 79 K |
| Change in Working Capital | 13.6 | (4.6) | 2.5 | 1.5 | (5.2) | 0.1 |
| Cash From Operations | (14.2) | (22.5) | (10.4) | (11.0) | (10.4) | (6.8) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.3) | (6.2) | (10.3) | 47.3 K | (0.2) | (1.5) |
| Other Items | 0 | 10.0 | 25.0 | (35.0) | 0 | 164 |
| Cash From Investing Activities | (0.3) | 3.8 | 14.7 | (35.0) | (0.2) | (1.5) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 6.8 | 38.3 K | 6.4 | 0 | 0.6 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.8) | 0 | 0 |
| Other Financing Activities | 2.3 | 0 | (0.2) | (6.8) | 22.3 | 26.8 |
| Cash From Financing Activities | 15.6 | 14.5 K | 6.3 | 49.3 | 11.7 | 13.4 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 1.1 | (18.7) | 10.6 | 3.3 | 1.1 | 5.2 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (14.5) | (28.7) | (20.7) | (11.0) | (10.6) | (8.2) |